Literature DB >> 32416316

PB-Net: Automatic peak integration by sequential deep learning for multiple reaction monitoring.

Zhenqin Wu1, Daniel Serie2, Gege Xu2, James Zou3.   

Abstract

Mass spectrometry (MS) based proteomics has become an indispensable component of modern molecular and cellular biochemistry analysis. Multiple reaction monitoring (MRM) is one of the most well-established MS techniques for molecule detection and quantification. Despite its wide usage, there lacks an accurate computational framework to analyze MRM data, and expert annotation is often required, especially to perform peak integration. Here we propose a deep learning method PB-Net (Peak Boundary Neural Network), built upon recent advances in sequential neural networks, for fully automatic chromatographic peak integration. To train PB-Net, we generated a large dataset of over 170,000 expert annotated peaks from MS transitions spanning a wide dynamic range, including both peptides and intact glycopeptides. Our model demonstrated outstanding performances on unseen test samples, reaching near-perfect agreement (Pearson's r 0.997) with human annotated ground truth. Systematic evaluations also show that PB-Net is substantially more robust and accurate compared to previous state-of-the-art peak integration software. PB-Net can benefit the wide community of mass spectrometry data analysis, especially in applications involving high-throughput MS experiments. Codes and test data used in this work are available at https://github.com/miaecle/PB-net. SIGNIFICANCE: Human annotations serve an important role in accurate quantification of multiple reaction monitoring (MRM) experiments, though they are costly to collect and limit analysis throughput. In this work we proposed and developed a novel technique for the peak-integration step in MRM, based on recent innovations in sequential deep learning models. We collected in total 170,000 expert-annotated MRM peaks and trained a set of accurate and robust neural networks for the task. Results demonstrated a substantial improvement over the current state-of-the-art software for mass spectrometry analysis and comparable level of accuracy and precision as human annotators.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deep learning; Glycoproteomics; Machine learning; Mass spectrometry

Mesh:

Substances:

Year:  2020        PMID: 32416316     DOI: 10.1016/j.jprot.2020.103820

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  5 in total

Review 1.  Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective.

Authors:  Konstantinos Flevaris; Cleo Kontoravdi
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

Review 2.  Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy.

Authors:  Yeonggyeong Park; Min Jeong Kim; Yoonhee Choi; Na Hyun Kim; Leeseul Kim; Seung Pyo Daniel Hong; Hyung-Gyo Cho; Emma Yu; Young Kwang Chae
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 12.469

3.  Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.

Authors:  Prasanna Ramachandran; Gege Xu; Hector H Huang; Rachel Rice; Bo Zhou; Klaus Lindpaintner; Daniel Serie
Journal:  J Proteome Res       Date:  2022-03-14       Impact factor: 4.466

4.  Glycosylation alterations in serum of Alzheimer's disease patients show widespread changes in N-glycosylation of proteins related to immune function, inflammation, and lipoprotein metabolism.

Authors:  Jennyfer Tena; Xinyu Tang; Qingwen Zhou; Danielle Harvey; Maria Barajas-Mendoza; Lee-Way Jin; Izumi Maezawa; Angela M Zivkovic; Carlito B Lebrilla
Journal:  Alzheimers Dement (Amst)       Date:  2022-04-27

5.  Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19.

Authors:  Chad Pickering; Bo Zhou; Gege Xu; Rachel Rice; Prasanna Ramachandran; Hector Huang; Tho D Pham; Jeffrey M Schapiro; Xin Cong; Saborni Chakraborty; Karlie Edwards; Srinivasa T Reddy; Faheem Guirgis; Taia T Wang; Daniel Serie; Klaus Lindpaintner
Journal:  Viruses       Date:  2022-03-07       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.